Cancer Genetics Inc. added Thomas Widmann to its board.
Widmann is currently with German venture capital firm Wellington Partners as a venture partner.
Cancer Genetics appoints director
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Cancer Genetics Inc. added Thomas Widmann to its board.
Widmann is currently with German venture capital firm Wellington Partners as a venture partner.